A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

ClinicalTrials.gov ID: NCT07219173

Public ClinicalTrials.gov record NCT07219173. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 16, 2026, 10:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-blind, 52-week Study, to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Uncontrolled Moderate to Severe Asthma

Study identification

NCT ID: NCT07219173
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Eli Lilly and Company; Industry
Enrollment: 531 participants

Conditions and interventions

Conditions

Asthma

Interventions

Brenipatide Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 75 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 21, 2025
Primary completion: Mar 31, 2028
Completion: May 31, 2028
Last update posted: May 13, 2026

2025 – 2028

United States locations

U.S. sites: 17
U.S. states: 11
U.S. cities: 16

Facility	City	State	ZIP	Site status
AMR Clinical	Tempe	Arizona	85281	Recruiting
NewportNativeMD, Inc.	Newport Beach	California	92663	Recruiting
California Medical Research Associates	Northridge	California	91324	Recruiting
Peninsula Research Associates	Rolling Hills Estates	California	90274	Recruiting
Asthma & Allergy Associates - Colorado Springs	Colorado Springs	Colorado	80907	Recruiting
AMR Clinical	Doral	Florida	33172-2514	Recruiting
Renstar Medical Research	Ocala	Florida	34470	Recruiting
Avanza Medical Research Center	Pensacola	Florida	32503	Recruiting
USF Health	Tampa	Florida	33613	Recruiting
Axis Clinical Trials - Westchester	Westchester	Illinois	60154	Recruiting
Allergy & Asthma Specialists, P.S.C.	Owensboro	Kentucky	42301	Recruiting
Brigham and Women's Hospital	Boston	Massachusetts	02115	Recruiting
AMR Clinical	Las Vegas	Nevada	89119	Recruiting
Equity Medical	New York	New York	10455	Recruiting
University of Pittsburgh Medical Center	Pittsburgh	Pennsylvania	15213	Not yet recruiting
Allergy and Clinical Immunology Associates	Pittsburgh	Pennsylvania	15241	Recruiting
Vanderbilt Asthma, Sinus and Allergy Program	Nashville	Tennessee	37203	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 105 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07219173, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 13, 2026 · Synced May 16, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07219173 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →